Literature DB >> 24074178

Role of colchicine-induced microtubule depolymerization in hyperalgesia via TRPV4 in rats with chronic compression of the dorsal root ganglion.

Liping Ning, Chuanwei Wang, Xiaohua Fan, Xinli Ding, Yonghui Wang, Yang Zhang, Jie Wang, Shouwei Yue.   

Abstract

The aim of this study is to investigate the effect of microtubule depolymerization by colchicine on hyperalgesia mediated by transient receptor potential vanilloid 4 (TRPV4) in a neuropathic pain model of chronic compression of the dorsal root ganglion (DRG) (hereafter termed CCD) in rat. Intrathecal administration of microtubule-depolymerizing agent, colchicine, attenuated the activated effect of 4alpha-phorbol 12, 13-didecanoate (4alpha-PDD, TRPV4 specific agonist) on mechanical and thermal hyperalgesia in CCD rats. This observation is in agreement with our in vitro experiments with DRG cells that showed a significant attenuation of 4alpha-PDD-activated Ca(2+)-influx and substance P (SP) release with the colchicine treatment. We conclude that microtubule depolymerization by colchicine can regulate pain sensitivity by depressing the hyperalgesia mediated by TRPV4.

Entities:  

Keywords:  CCD; Colchicine,; Hyperalgesia,; Microtubule depolymerization,; Transient receptor potential vanilloid 4,

Mesh:

Substances:

Year:  2013        PMID: 24074178     DOI: 10.1179/1743132813Y.0000000261

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  3 in total

1.  Cdk5 inhibitor roscovitine alleviates neuropathic pain in the dorsal root ganglia by downregulating N-methyl-D-aspartate receptor subunit 2A.

Authors:  Lei Yang; Xiaoping Gu; Wei Zhang; Juan Zhang; Zhengliang Ma
Journal:  Neurol Sci       Date:  2014-09       Impact factor: 3.307

2.  Role of TRPV4-P2X7 Pathway in Neuropathic Pain in Rats with Chronic Compression of the Dorsal Root Ganglion.

Authors:  Xiaohua Fan; Chuanwei Wang; Junting Han; Xinli Ding; Shaocan Tang; Liping Ning
Journal:  Neurochem Res       Date:  2021-05-20       Impact factor: 3.996

3.  Small molecule dual-inhibitors of TRPV4 and TRPA1 for attenuation of inflammation and pain.

Authors:  Patrick Kanju; Yong Chen; Whasil Lee; Michele Yeo; Suk Hee Lee; Joelle Romac; Rafiq Shahid; Ping Fan; David M Gooden; Sidney A Simon; Ivan Spasojevic; Robert A Mook; Rodger A Liddle; Farshid Guilak; Wolfgang B Liedtke
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.